Cargando…

International Differences in Outpatient Pain Management: A Survey of Sickle Cell Disease

Vaso-occlusive pain crises are the hallmark of sickle cell disease (SCD) and the primary reason for health care utilization. Both national and international guidelines recommend aggressive intravenous opioids, intravenous fluids and anti-inflammatory therapy as the mainstay of treatment for acute SC...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Amin, Nadirah, Nietert, Paul, Kanter, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947541/ https://www.ncbi.nlm.nih.gov/pubmed/31817043 http://dx.doi.org/10.3390/jcm8122136

Ejemplares similares

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020)

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium
por: Masese, Rita V., et al.
Publicado: (2021)

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program
por: Sheppard, Sydney, et al.
Publicado: (2021)

Emergency department utilization for sickle cell disease in St. Vincent and the Grenadines
por: Williams, Shelly-Ann, et al.
Publicado: (2021)

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations
por: Cabana, Michael D., et al.
Publicado: (2019)

Definity, an affinity for painful crisis: a case series describing vaso-occlusive pain crises in sickle cell patients undergoing echocardiogram with Definity contrast
por: D’Amico, Alex, et al.
Publicado: (2020)

Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2021)

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
por: Smeltzer, Matthew P, et al.
Publicado: (2021)

Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease
por: Plonski, Krystal S.
Publicado: (2022)

Precision, integrative medicine for pain management in sickle cell disease
por: Smith, Wally R., et al.
Publicado: (2023)

Validation of a novel point of care testing device for sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2015)

Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study
por: Kanter, Julie, et al.
Publicado: (2018)

Management of Patients with Sickle Cell Pain in the Community
por: Edmonds, Polly, et al.
Publicado: (1999)

A Stress and Pain Self-management mHealth App for Adult Outpatients With Sickle Cell Disease: Protocol for a Randomized Controlled Study
por: Ezenwa, Miriam O, et al.
Publicado: (2022)

Perspectives of individuals with sickle cell disease on barriers to care
por: Phillips, Shannon, et al.
Publicado: (2022)

High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
por: Kanter, Julie, et al.
Publicado: (2019)

Association Between Patent Foramen Ovale and Overt Ischemic Stroke in Children With Sickle Cell Disease
por: Galadanci, Najibah A., et al.
Publicado: (2021)

Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
por: Ward, Joel, et al.
Publicado: (2018)

Management of Sickle Cell Disease Pain among Adolescent and Pediatric Patients
por: Abdo, Samar, et al.
Publicado: (2019)

Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study
por: Galadanci, Najibah A., et al.
Publicado: (2022)

P-053: SICKLE CELL MANAGEMENT AND INTERNATIONAL COOPERATION
por: I., DEME LY, et al.
Publicado: (2022)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

An unusual ultrasound appearance of renal hemosiderosis in acute sickle cell nephropathy
por: Kocher, Madison, et al.
Publicado: (2019)

Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management
por: Uwaezuoke, Samuel N, et al.
Publicado: (2018)

Peer Mediated Groups:: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2022)

Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis
por: Aghamolaei, Teamur, et al.
Publicado: (2022)

Morphine for the Treatment of Pain in Sickle Cell Disease
por: Gupta, Mihir, et al.
Publicado: (2015)

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care
por: Kanter, Julie, et al.
Publicado: (2020)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program
por: Williams, Shelly-Ann, et al.
Publicado: (2017)

Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study
por: Bakshi, Nitya, et al.
Publicado: (2022)

Development of a Severity Classification System for Sickle Cell Disease
por: Shah, Nirmish, et al.
Publicado: (2020)

Asthma Management in Sickle Cell Disease
por: Gomez, Esteban, et al.
Publicado: (2013)

Perioperative Management of Sickle Cell Disease
por: Adjepong, Kwame Ofori, et al.
Publicado: (2018)

Management of refractory chronic pain in sickle cell disease with intrathecal drug delivery system
por: Mendes, Plinio Duarte, et al.
Publicado: (2023)

Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia
por: Piety, Nathaniel Z., et al.
Publicado: (2016)

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: B., ANDEMARIAM, et al.
Publicado: (2022)

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020)

Transfusion Practices in the Management of Sickle Cell Disease: A Survey of Florida Hematologists/Oncologists
por: Dunbar, Levette N., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dc6m01kaqne7fthr6a82tkgetq